Dyslipidemia-related Risk Factors in Dialysis
|ClinicalTrials.gov Identifier: NCT02072837|
Recruitment Status : Completed
First Posted : February 27, 2014
Last Update Posted : February 28, 2014
|Condition or disease|
|Chronic Renal Disease Cardiovascular Disease Dyslipidemia|
Blood samples were obtained by venipuncture in the peritoneal dialyzed patients and control group in a twelve hours fasting state.In hemodialyzed patients blood was drawn just before the start of the mean weekly dialysis session also in a twelve hours fasting state from the vascular access.
All samples were received once at baseline time ( in the start of the study ). Peripheral systolic and diastolic blood pressures were calculated as an average of 10 measurements during a renal replacement treatment month in the starting time of the study.
Also, electrocardiographic examination, echocardiography and the calculation of ankle-brachial blood pressure index became once in the start of the study.
|Study Type :||Observational|
|Actual Enrollment :||96 participants|
|Observational Model:||Case Control|
|Official Title:||Dyslipidemia-related Variables as Risk Factor for Cardiovascular Disease in Patients on the End-stage of Renal Disease|
|Study Start Date :||January 2012|
|Primary Completion Date :||January 2014|
|Study Completion Date :||January 2014|
- Associations between dyslipidemia with cardiovascular disease on patients on renal replacement therapy [ Time Frame: February 2014 ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02072837
|Principal Investigator:||Vaia D. Raikou, Ph.D||National & Kapodistrian University of Athens, School of Medicine|